文献速递肝病

非酒精性脂肪性肝病中体力活动与肝纤维化、肌少症及心血管疾病风险的关联

Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-01-06

这项多中心回顾性研究纳入2014至2020年间接受健康筛查的11690例非酒精性脂肪性肝病患者,评估体力活动(MET-min/周)与肝纤维化、肌少症及心血管疾病风险的关联。体力活动超过600 MET-min/周(≥第三四分位数)与纤维化、肌少症、ASCVD高概率及高CAC评分风险降低独立相关。

要点

  • 纤维化、肌少症、ASCVD高概率及高CAC评分的患病率随体力活动四分位数增加而显著下降(趋势P<.001)。
  • 体力活动>600 MET-min/周与纤维化风险降低独立相关(aOR=0.59;95%CI 0.40-0.86)。
  • 体力活动>600 MET-min/周与肌少症、ASCVD高概率及高CAC评分风险降低独立相关(aOR分别为0.72、0.58、0.32)。

核心结论

  • 体力活动对非酒精性脂肪性肝病患者的纤维化、肌少症和心血管疾病显示出保护作用。

研究设计与样本

  • 多中心回顾性研究,纳入2014至2020年间接受健康筛查并评估体力活动(MET-min/周)的11690例非酒精性脂肪性肝病患者。
  • 肝纤维化采用纤维化-4指数、NAFLD纤维化评分和FibroScan-AST评分评估,肌少症采用多频生物电阻抗分析评估,心血管疾病风险采用动脉粥样硬化性心血管疾病(ASCVD)风险评分和冠状动脉钙化(CAC)评分计算。

主要发现

  • 纤维化、肌少症、ASCVD高概率和高CAC评分的患病率随体力活动四分位数增加而显著下降(所有趋势P<.001)。
  • 在完全校正模型中,体力活动超过600 MET-min/周(≥第三四分位数)与纤维化风险降低独立相关(aOR=0.59;95%CI 0.40-0.86)。
  • 体力活动超过600 MET-min/周与肌少症风险降低独立相关(aOR=0.72;95%CI 0.58-0.88)。
  • 体力活动超过600 MET-min/周与ASCVD高概率风险降低独立相关(aOR=0.58;95%CI 0.46-0.73),与高CAC评分风险降低独立相关(aOR=0.32;95%CI 0.13-0.83;所有P<.05)。
  • 体力活动量增加与纤维化、肌少症和ASCVD高概率风险降低显著相关(所有趋势P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: International guidelines recommend physical activity for subjects with nonalcoholic fatty liver disease (NAFLD). This study investigated the association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease (CVD) in NAFLD. METHODS: In this multicenter, retrospective study, 11,690 NAFLD subjects who underwent a health screening program and were assessed for physical activity (metabolic equivalent task [MET]-min/week) between 2014 and 2020 were recruited. Liver fibrosis was assessed by using the fibrosis-4 index, NAFLD fibrosis score, and FibroScan-AST score, sarcopenia by using multi-frequency bioelectric impedance analysis, and CVD risk by using atherosclerotic CVD (ASCVD) risk score, and coronary artery calcium (CAC) score were calculated. RESULTS: The prevalence of fibrosis, sarcopenia, high probability of ASCVD, and high CAC score significantly decreased with increasing quartiles of physical activity (all P for trend <.001). In a fully adjusted model, physical activity above 600 MET-min/week (≥third quartile) was independently associated with a reduced risk of fibrosis (adjusted odds ratio [aOR] = 0.59; 95% confidence interval [CI], 0.40-0.86), sarcopenia (aOR = 0.72; 95% CI, 0.58-0.88), high probability of ASCVD (aOR = 0.58; 95% CI, 0.46-0.73), and high CAC score (aOR = 0.32; 95% CI, 0.13-0.83; all P <.05). In addition, increasing amounts of physical activity were significantly associated with risk reduction between fibrosis, sarcopenia, and high probability of ASCVD (all P for trend <.001). In subjects with sarcopenic obesity or lean NAFLD, physical activity was also independently associated with reduced risk of fibrosis and high probability of ASCVD (all P <.05). CONCLUSIONS: Physical activity showed a protective effect against fibrosis, sarcopenia, and CVD in NAFLD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Chun HS, Lee M, Lee HA, et al. Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022. PMID: 34998993. doi:10.1016/j.cgh.2021.12.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。